# Dr. Heidi Overton

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/dr-heidi-overton
Canonical HTML page: https://gethealthbrief.com/entity/dr-heidi-overton

## Timeline

- **2026-08-19T20:15:00Z**: Hartford Courant reports Trump picks Overton — The Hartford Courant reports Trump picks Dr. Heidi Overton, a top White House aide, to lead the FDA.
- **2026-08-19T20:00:00Z**: ABC7 News reports Trump picks Overton — ABC7 News publishes a headline stating Trump picks Dr. Heidi Overton, a top White House aide, to lead the FDA.
- **2026-08-19T01:18:25Z**: STAT News reports Trump expected to pick Overton — STAT reports that President Trump is expected to choose White House adviser and physician Heidi Overton to lead the Food and Drug Administration.
- **2026-08-19**: Trump announces Heidi Overton as FDA Commissioner nominee — President Trump names the White House Domestic Policy Council deputy director to lead the FDA, pending Senate confirmation.
- **2026-05**: Marty Makary resigns as FDA Commissioner — The previous FDA head leaves behind unfinished projects on ultraprocessed foods, antidepressants, and COVID-19 shots.

## Recent coverage (2 stories)

### Overton's FDA Pick: 3 Regulatory Fault Lines for Health Tech
2026-08-20 00:44:20 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

For health IT, medical device and telehealth leaders, Overton's nomination signals a period of regulatory uncertainty. Her backing of MAHA and most favored nation drug pricing could reshape digital health evidence standards, diagnostics oversight and vaccine-adjacent software, even as deregulatory forces promise faster approvals. Confirmation will test how the FDA balances innovation with public health safeguards.
Full story: https://gethealthbrief.com/story/overton-fda-health-tech-regulatory-fault-lines

### Heidi Overton FDA pick: 3 regulatory areas health IT should watch
2026-08-19 21:12:01 · Sentiment: Neutral · Impact: 7/10 · Sources: 3

Reports that Dr. Heidi Overton will be nominated to lead FDA introduce new regulatory uncertainty for health IT vendors, medical device manufacturers, and digital health companies. As a White House adviser without a public FDA track record, her stance on software-as-a-medical-device, telehealth, and AI-enabled diagnostics is unclear. Health technology leaders should monitor confirmation and early policy signals.
Full story: https://gethealthbrief.com/story/overton-fda-health-it-regulatory-watch

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.